
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SEMA4B CRISPR/Cas9 KO Plasmid (m) | sc-422881 | 20 µg | $397.00 |
Sema4b encodes the transmembrane guidance cue SEMA4B, a class 4 semaphorin that participates in contact-dependent signaling to regulate cell adhesion, migration, and cytoskeletal remodeling. In mouse tissues, SEMA4B contributes to axon guidance and synaptic organization and has been implicated in glial and neuronal responses to inflammatory and injury-related cues. Semaphorin signaling intersects with pathways controlling Rho-family GTPases and receptor-associated kinase cascades, shaping directional motility and tissue patterning. Dysregulated semaphorin networks, including SEMA4B-associated signaling, are studied in contexts of neurodevelopmental perturbation, neuroinflammation, and tumor–microenvironment interactions where guidance signals influence invasion and immune cell positioning.
SEMA4B CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Sema4b gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Sema4b together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Sema4b open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SEMA4B protein expression.
This CRISPR knockout system enables efficient generation of Sema4b-deficient cell models for investigation of SEMA4B signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.